Clinical Diversity in Patients with Anderson-fabry Disease with the R301Q Mutation

Intern Med. 2019 Feb 15;58(4):603-607. doi: 10.2169/internalmedicine.0959-18. Epub 2018 Oct 17.

Abstract

Anderson-Fabry disease (AFD) is a rare X-linked disorder caused by deficient activity of the lysosomal enzyme α-galactosidase A (α-GAL A). We herein report 10 cases of AFD in 5 families (3 men and 7 women) that were found to have a specific common mutation in R301Q [G-to-A transition in exon 6 (codon 301) resulting in the replacement of a glutamine with an arginine residue]. We evaluated their clinical characteristics, residual enzymatic activity, and plasma concentrations of globotriaosylsphingosine (Lyso-Gb3). Although all 10 cases had cardiac and renal manifestations in common, their clinical manifestations were markedly divergent despite the same genetic abnormality.

Keywords: Anderson-Fabry disease; hypertrophic cardiomyopathy; renal failure; ɑ-galactosidase mutant (R301Q).

MeSH terms

  • Adult
  • Aged
  • Fabry Disease / genetics*
  • Fabry Disease / physiopathology*
  • Female
  • Glycolipids / genetics*
  • Humans
  • Male
  • Middle Aged
  • Mutation*
  • Sex Factors
  • Sphingolipids / genetics*
  • Young Adult
  • alpha-Galactosidase / genetics*

Substances

  • Glycolipids
  • Sphingolipids
  • globotriaosyl lysosphingolipid
  • alpha-Galactosidase